Hainan Poly Pharm Future Growth
Future criteria checks 3/6
Hainan Poly Pharm is forecast to grow earnings and revenue by 21.5% and 18.1% per annum respectively. EPS is expected to grow by 20.4% per annum. Return on equity is forecast to be 14.7% in 3 years.
Key information
21.5%
Earnings growth rate
20.4%
EPS growth rate
Pharmaceuticals earnings growth | 19.2% |
Revenue growth rate | 18.1% |
Future return on equity | 14.7% |
Analyst coverage | Low |
Last updated | 01 Dec 2023 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 2,766 | 646 | N/A | 723 | 2 |
12/31/2024 | 2,377 | 550 | N/A | 641 | 2 |
12/31/2023 | 2,051 | 473 | N/A | 305 | 2 |
9/30/2023 | 1,788 | 369 | -226 | 483 | N/A |
6/30/2023 | 1,845 | 403 | -304 | 537 | N/A |
3/31/2023 | 1,812 | 397 | -557 | 541 | N/A |
12/31/2022 | 1,806 | 421 | -503 | 534 | N/A |
9/30/2022 | 1,743 | 482 | -869 | 83 | N/A |
6/30/2022 | 1,681 | 479 | -950 | 166 | N/A |
3/31/2022 | 1,603 | 457 | -689 | 168 | N/A |
1/1/2022 | 1,509 | 417 | -647 | 157 | N/A |
9/30/2021 | 1,543 | 513 | -737 | 380 | N/A |
6/30/2021 | 1,410 | 474 | -571 | 343 | N/A |
3/31/2021 | 1,291 | 449 | -495 | 337 | N/A |
12/31/2020 | 1,189 | 407 | -504 | 332 | N/A |
9/30/2020 | 1,124 | 380 | -385 | 251 | N/A |
6/30/2020 | 1,000 | 340 | -356 | 228 | N/A |
3/31/2020 | 964 | 311 | -355 | 217 | N/A |
12/31/2019 | 950 | 301 | -187 | 215 | N/A |
9/30/2019 | 830 | 266 | -161 | 21 | N/A |
6/30/2019 | 725 | 231 | -197 | 102 | N/A |
3/31/2019 | 687 | 220 | -140 | 98 | N/A |
12/31/2018 | 624 | 181 | -157 | 95 | N/A |
9/30/2018 | 528 | 159 | -185 | 206 | N/A |
6/30/2018 | 445 | 137 | -142 | 99 | N/A |
3/31/2018 | 371 | 119 | -168 | 95 | N/A |
12/31/2017 | 325 | 98 | -81 | 94 | N/A |
9/30/2017 | 298 | 89 | -69 | 84 | N/A |
6/30/2017 | 275 | 78 | N/A | 74 | N/A |
3/31/2017 | 260 | 72 | N/A | 56 | N/A |
12/31/2016 | 248 | 70 | N/A | 56 | N/A |
6/30/2016 | 214 | 56 | N/A | 43 | N/A |
3/31/2016 | 193 | 50 | N/A | 47 | N/A |
12/31/2015 | 203 | 51 | N/A | 58 | N/A |
12/31/2014 | 165 | 37 | N/A | 57 | N/A |
12/31/2013 | 132 | 25 | N/A | 45 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300630's forecast earnings growth (21.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 300630's earnings (21.5% per year) are forecast to grow slower than the CN market (24.1% per year).
High Growth Earnings: 300630's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300630's revenue (18.1% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 300630's revenue (18.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300630's Return on Equity is forecast to be low in 3 years time (14.7%).